• Skip to main content
  • Skip to footer
NDRI Logo
NDRI Digital NewsletterSpring 2022 Previous Issues
nexus

nexus

Advancing Medical Research Through Organ and Tissue Donation

NDRI Board Welcomes Molecular Virologist and Gene Expression Expert

Paul M. Lieberman, Ph.D., the Hilary Koprowski, M.D., Endowed Professor, has joined the NDRI Board of Directors.

April 6, 2022 by demitri

Paul M. Lieberman, Ph.D., the Hilary Koprowski, M.D., Endowed Professor, leader of the Gene Expression and Regulation Program, and director of the Center for Chemical Biology & Translational Medicine at The Wistar Institute, a biomedical research leader in cancer, immunology, infectious disease, and vaccine development, has joined the NDRI Board of Directors. Elected on November 12 to a three-year term, Lieberman will bring his experience and insight to the nation’s leading source of human organs, cells, and tissues for research. 

Lieberman is a molecular virologist and an expert in gene expression and regulation at Wistar’s Cancer Center. He is best known for his pioneering studies on how certain viruses can persist in the body long-term, leading to cancer. He leads a talented drug-discovery team that created first-in-class molecules directed against Epstein-Barr virus (EBV) as a novel therapeutic approach for potentially treating EBV-associated cancers.  

Lieberman earned a B.A. in Chemistry from Cornell University and a Ph.D. in pharmacology/virology from the Johns Hopkins University School of Medicine. He completed post-doctoral training at the University of California in Los Angeles. Lieberman’s research has been cited in over 150 publications. In 2018, Lieberman was named a 2018 Fellow of the Association of American Advancement of Sciences (AAAS).  

Mary J.C. Hendrix, Ph.D., Chair of the NDRI Board and President of Shepherd University, shared; “We are thrilled to welcome Dr. Lieberman to the NDRI Board of Directors. His scientific expertise and accomplishments and strong commitment to the advancement of research will serve as great contributions to NDRI’s mission.”  

Category iconSpring 2022

Tribute to Long-Time NDRI Board Member and Chair Emeritus Dr. Hal Broxmeyer
NDRI Logo

Footer

National Disease Research Interchange

Three Parkway
1601 Cherry Street, Suite 1700
Philadelphia,PA 19102
Main (215) 557-7361
Toll-Free (800) 222-NDRI (6374)
General info@ndriresource.org
Researchers research@ndriresource.org
NDRI is a Not-For-Profit (501c3)Corporation.
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube